Computed tomography volumetry of esophageal cancer - the role of semiautomatic assessment

BackgroundThe clinical and research value of Computed Tomography (CT) volumetry of esophageal cancer tumor size remains controversial. Development in CT technique and image analysis has made CT volumetry less cumbersome and it has gained renewed attention. The aim of this study was to assess esophageal tumor volume by semi-automatic measurements as compared to manual.MethodsA total of 23 esophageal cancer patients (median age 65, range 51–71), undergoing CT in the portal-venous phase for tumor staging, were retrospectively included between 2007 and 2012. One radiology resident and one consultant radiologist measured the tumor volume by semiautomatic segmentation and manual segmentation. Reproducibility of the respective measurements was assessed by intraclass correlation coefficients (ICC) and by average deviation from mean.ResultsMean tumor volume was 46 ml (range 5-137 ml) using manual segmentation and 42 ml (range 3-111 ml) using semiautomatic segmentation. Semiautomatic measurement provided better inter-observer agreement than traditional manual segmentation. The ICC was significantly higher for semiautomatic segmentation in comparison to manual segmentation (0.86, 0.56, p < 0.01). The average absolute percentage difference from mean was reduced from 24 to 14% (p < 0.001) when using semiautomatic segmentation.ConclusionsSemiautomatic analysis outperforms manual analysis for assessment of esophageal tumor volume, improving reproducibility.

[1]  B. Krause,et al.  New trends for staging and therapy for localized gastroesophageal cancer: the role of PET. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

[2]  S. Leung,et al.  Assessing chemotherapy response of squamous cell oesophageal carcinoma with spiral CT. , 1999, The British journal of radiology.

[3]  Wolfgang Schröder,et al.  Predicting response to neoadjuvant therapy in esophageal cancer , 2011, Expert review of anticancer therapy.

[4]  C. Metreweli,et al.  Oesophageal tumour volume measurement using spiral CT , 1996 .

[5]  D. Low Update on Staging and Surgical Treatment Options for Esophageal Cancer , 2011, Journal of Gastrointestinal Surgery.

[6]  R. Cerfolio,et al.  The accuracy of endoscopic ultrasonography with fine-needle aspiration, integrated positron emission tomography with computed tomography, and computed tomography in restaging patients with esophageal cancer after neoadjuvant chemoradiotherapy. , 2005, The Journal of thoracic and cardiovascular surgery.

[7]  A Comparison of Repeatability and Usability of Semi-Automated Volume Segmentation Tools for Measurement of Vestibular Schwannomas. , 2018, Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology.

[8]  K. Miles,et al.  Tumour heterogeneity in oesophageal cancer assessed by CT texture analysis: preliminary evidence of an association with tumour metabolism, stage, and survival. , 2012, Clinical radiology.

[9]  R. Reznek,et al.  CT assessment of tumour response to treatment: comparison of linear, cross-sectional and volumetric measures of tumour size. , 2000, The British journal of radiology.

[10]  A. Beckett,et al.  AKUFO AND IBARAPA. , 1965, Lancet.

[11]  J. Lagergren,et al.  Survival after surgery for oesophageal cancer: a population-based study. , 2005, The Lancet. Oncology.

[12]  A. Ba-Ssalamah,et al.  Change in volume parameters induced by neoadjuvant chemotherapy provide accurate prediction of overall survival after resection in patients with oesophageal cancer , 2016, European Radiology.

[13]  Wolfgang A Weber,et al.  PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial. , 2007, The Lancet. Oncology.

[14]  L. Lundell,et al.  Texture analysis of computed tomography data using morphologic and metabolic delineation of esophageal cancer-relation to tumor type and neoadjuvant therapy response. , 2018, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[15]  V. Goh,et al.  Primary esophageal cancer: heterogeneity as potential prognostic biomarker in patients treated with definitive chemotherapy and radiation therapy. , 2013, Radiology.

[16]  P. Bossuyt,et al.  Accuracy and reproducibility of 3D-CT measurements for early response assessment of chemoradiotherapy in patients with oesophageal cancer. , 2011, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[17]  D. Altman,et al.  STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT , 1986, The Lancet.

[18]  R. Munden,et al.  Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer. , 2004, The Annals of thoracic surgery.

[19]  Unbiased estimation of tumor regression rates during chemoradiotherapy for esophageal carcinoma using CT and stereology. , 2005, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[20]  E. Rummeny,et al.  Adenocarcinomas of esophagogastric junction: multi-detector row CT to evaluate early response to neoadjuvant chemotherapy. , 2006, Radiology.

[21]  G. Sloof Response monitoring of neoadjuvant therapy using CT, EUS, and FDG-PET. , 2006, Best practice & research. Clinical gastroenterology.

[22]  J. Bosset,et al.  Tumor Volume as Outcome Determinant in Patients Treated With Chemoradiation for Locally Advanced Esophageal Cancer , 2006, American journal of clinical oncology.

[23]  S. Friesland,et al.  A randomized clinical trial of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the oesophagus or gastro-oesophageal junction. , 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

[24]  V Goh,et al.  Assessment of changes in tumor heterogeneity following neoadjuvant chemotherapy in primary esophageal cancer. , 2015, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[25]  L. Lundell,et al.  Predictors of postoperative morbidity and mortality after surgery for gastro-oesophageal carcinomas. , 1995, The European journal of surgery = Acta chirurgica.

[26]  J. Lagendijk,et al.  Diffusion-weighted magnetic resonance imaging for the prediction of pathologic response to neoadjuvant chemoradiotherapy in esophageal cancer. , 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[27]  G. Eslick,et al.  Safety and efficacy of esophageal stents preceding or during neoadjuvant chemotherapy for esophageal cancer: a systematic review and meta-analysis. , 2014, Journal of gastrointestinal oncology.

[28]  Dimitris Visvikis,et al.  Characterization of PET/CT images using texture analysis: the past, the present… any future? , 2016, European Journal of Nuclear Medicine and Molecular Imaging.

[29]  G. Peters,et al.  Positron emission tomography using 2-deoxy-2-[18F]-fluoro-D-glucose for response monitoring in locally advanced gastroesophageal cancer; a comparison of different analytical methods. , 2003, Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging.

[30]  S. Larson,et al.  Positron emission tomography/computerized tomography functional imaging of esophageal and colorectal cancer. , 2004, Cancer journal.

[31]  J. S. Kim,et al.  Comparison of endoscopic ultrasonography (EUS), positron emission tomography (PET), and computed tomography (CT) in the preoperative locoregional staging of resectable esophageal cancer , 2009, Surgical Endoscopy.

[32]  E Bellon,et al.  Laryngeal tumor volume measurements determined with CT: a study on intra- and interobserver variability. , 1998, International journal of radiation oncology, biology, physics.

[33]  B. Krause,et al.  Curative treatment of oesophageal carcinoma: current options and future developments , 2011, Radiation oncology.

[34]  C. Mariette,et al.  Therapeutic strategies in oesophageal carcinoma: role of surgery and other modalities. , 2007, The Lancet. Oncology.

[35]  Tian-wu Chen,et al.  Intravoxel incoherent motion diffusion-weighted imaging of resectable oesophageal squamous cell carcinoma: association with tumour stage. , 2018, The British journal of radiology.

[36]  F. Detterbeck,et al.  Inadequacy of computed tomography in assessing patients with esophageal carcinoma after induction chemoradiotherapy , 1999, Cancer.

[37]  I. B. Borel Rinkes,et al.  International survey on esophageal cancer: part II staging and neoadjuvant therapy. , 2009, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[38]  Vicky Goh,et al.  The precision of textural analysis in 18F-FDG-PET scans of oesophageal cancer , 2015, European Radiology.

[39]  F. Giganti,et al.  Apparent diffusion coefficient modifications in assessing gastro-oesophageal cancer response to neoadjuvant treatment: comparison with tumour regression grade at histology , 2013, European Radiology.

[40]  J. W. Beck,et al.  Volume determinations using computed tomography. , 1982, AJR. American journal of roentgenology.